Investment
HTH VC (Zambon Group) participated in a $5M Series A round for Leuko, a digital health startup developing non-invasive white blood cell monitoring for cancer patients.
Leuko
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Leuko
Endostart
Lys Therapeutics
EpilepsyGTX
EpilepsyGTX
Lys Therapeutics
Leuko
Hyivy Health